top of page

A Strategic Leap or a Loss for New Zealand As NewFish Heads To The US

In a move aimed at capturing a significant share of the large U.S. sports and active lifestyle nutrition market, New Zealand biotechnology company, NewFish, has announced its entry into the US based IndieBio’s Batch 15 cohort. This strategic step is accompanied by substantial funding from SOSV and the establishment of its headquarters and laboratory in San Francisco.


NewFish is the first Australasian biotech entity to join IndieBio. The company, which has developed an innovative approach to obtaining nutritional protein from